USA Equities Corp (OTCMKTS:USAQ) Announces Prescription Product Expansion: Stock Flat

Shares of USA Equities Corp (OTCMKTS:USAQ) closed flat in the previous session. The stock has lost 20% in the past week.

Market Reaction

On Wednesday, USAQ stock ended flat at $0.5850 with 50 shares, compared to its average volume of 2.8k shares. The stock moved within a range of $0.5850 – 0.5850 after opening trade at $0.5850.

QHSLab Expands Digital Prescription Product Portfolio in 2022

Medical device company giving digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians, USA Equities Corp (OTCMKTS:USAQ) on February 16, 2022 announced newest digital medicine as well as point of care clinical decision-making tools, which would be brought into market in 2022.

The firm’s flagship product, QHSLab, is a decision support system combining medical guideline based recommendations and intelligent patient health risk assessments. QHSLab was made to address high-cost acuity as well as chronic health conditions with low-cost interventions.

Troy Grogan, President and CEO of USA Equities Corp said that the QHSLab is cloud-based platform for improving physician efficiency as well as reducing healthcare costs. Grogan added that the firm is thrilled on expanding product portfolio as well as offering comprehensive services to physicians. This will improve clinical outcomes.

QHSLab has launched comprehensive mental health risk assessment ‘Q-Scale’ as mental health concerns have become vital. NIH states that 1 in 5 adults face mental health issue with addressable market of about 53 million Americans. The lab is also releasing pain evaluation and musculoskeletal health.  Musculoskeletal health is seen as a significant area of focus for healthcare technology investors. Grogan added that telehealth and Virtual care are advancing as best practices in medicine. He added that the platform gives physicians with actionable insights into patients’ health.

Key Quote

“QHSLab is a cloud-based platform designed to improve physician efficiency and reduce healthcare costs – while playing an active role in making health risks more visible to the physician and patient,” said Troy Grogan, President and CEO of USA Equities Corp.

Traders Review

USAQ stock is trading below the 20-Day and 50-Day Moving averages of $0.60 and $0.63 respectively. Moreover, the stock is trading below the 200-Day moving average of $0.71.


Leave a Reply

Your email address will not be published.